Doxepin hydrochloride NDC 27241-170

Product information

Brand name (proprietary)

Doxepin hydrochloride

Generic name (nonproprietary)

doxepin hydrochloride

Active ingredients

Doxepin hydrochloride — 75 mg/1

Dosage form

Capsule

Route

Oral

Labeler

Ajanta Pharma USA Inc.

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 212624

Marketing start

Dec 20, 2019

Listing expires

Dec 31, 2027

Identifiers

Product ID 27241-170_fa508191-83f3-4352-8389-a7e3cb80cb1cSPL ID fa508191-83f3-4352-8389-a7e3cb80cb1cSPL set ID 1513c98c-e7ef-4009-b932-6757048bb86aRxCUI 1000048, 1000058, 1000070, 1000076, 1000097UNII 3U9A0FE9N5UPC 0327241167010, 0327241168017, 0327241171017, 0327241170010, 0327241169014

Pharmacologic class

Tricyclic Antidepressant

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N427241017001 followed by a unit qualifier and the quantity Copy

Package 27241-0170-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under ANDA 212624

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.